Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327322 · ClinicalTrials.gov registry record · NA
Functional Outcomes From Diets in Multiple Sclerosis
A NA study of Relapsing Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT05327322 is a NA study of Relapsing Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 199-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (50% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05327322, a NA study of Relapsing Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the effects of two dietary interventions, glycemic load and calorie restriction, on physical function, cognition, pain, fatigue, mood, and anxiety in adults with multiple sclerosis (MS). The investigators will also explore the how the diet interventions impact inflammation, immunity, and metabolic biomarkers.
Conditions Studied
Interventions
- BEHAVIORAL Glycemic load
- BEHAVIORAL Calorie restriction
- BEHAVIORAL Behavioral support
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05327322
The ClinicalTrials.gov registry entry for NCT05327322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 199-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (50% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 3 interventions - of which Glycemic load is the first listed.
NCT05327322 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Missouri.
Frequently Asked Questions
What is clinical trial NCT05327322 about?
NCT05327322 is a clinical study titled "Functional Outcomes From Diets in Multiple Sclerosis". The purpose of this study is to test the effects of two dietary interventions, glycemic load and calorie restriction, on physical function, cognition, pain, fatigue, mood, and anxiety in adults with multiple sclerosis (MS). The investigators will also explore the how the diet interventions impact in...
What is the current status of trial NCT05327322?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-03-20. Estimated completion is 2026-11-01.
What conditions does trial NCT05327322 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis.
What interventions are being tested in trial NCT05327322?
The interventions under investigation include: Glycemic load (BEHAVIORAL), Calorie restriction (BEHAVIORAL), Behavioral support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05327322?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05327322 being conducted?
This trial has 2 study locations across Alabama, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
ACTIVE NOT RECRUITING · NA
-
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
COMPLETED · NA
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
COMPLETED · NA
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
Explore more on PlainTrial
Relapsing Remitting Multiple Sclerosis
All registered trials for this condition
Secondary Progressive Multiple Sclerosis
All registered trials for this condition
Alabama
All trials with a study site in Alabama
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.